Introduction {#sec1-1}
============

The global increase in the mean lifespan and improvements in medical science have raised issues related to surgical approaches in elderly patients ^[@ref1]^. In particular, when primary functions such as swallowing, breathing and speaking are impaired, as is inevitable when treating malignancies in the upper aero-digestive tract, the importance of patient recovery and impact on the quality of residual life after surgical treatment should not be underestimated ^[@ref2][@ref3]^. Many authors have recently examined these issues, with particular focus on indications, success rates, complications and perioperative morbidity related to free-flap reconstruction in elderly patients with oral cavity tumours ^[@ref4]^. Most authors have concluded that comorbidities and performance status, rather than age, should be considered as risk and predictive factors ^[@ref9]^, as free-flap techniques are believed to be relatively safe in the elderly population ^[@ref10][@ref11]^.

However, little research has focused on the impact of such reconstruction on the quality of life (QOL) of elderly patients. Thus, we require a better understanding of patients' QOL after tumour treatment, in terms of surgery-related long-term morbidity, social life impairment and the psychological implications of such major interventions in a subset of patients usually considered to be frail. Comprehensive insight into this matter is of primary importance to better determine whether these procedures are indicated in the elderly population, as the quality of residual life (which is obviously shorter than in younger patients) is a primary issue that should be taken into account when treating these patients. In this study, we analyse the impact of major resection and reconstructive procedures on QOL in the population of patients over the age of 75.

Patients and methods {#sec1-2}
====================

This multicentre retrospective review of medical records involved five Italian academic tertiary-care institutions: the University Hospital of Parma, University Hospital Maggiore Policlinico of Milano, "Sant'Anna" Hospital of Como, University Hospital "Federico II" of Napoli, and "Casa Sollievo della Sofferenza" Hospital of San Giovanni Rotondo. Data from patients aged \> 75 years at the time of major head and neck reconstruction conducted with free flaps between 1 January 2005 and 30 June 2015 were analysed retrospectively. The data collected included age, sex, American Society of Anesthesiologists (ASA) status, alcohol and tobacco habits, history of oncological pathology, and comorbidities in four major areas (cardiovascular, kidney, liver, and lung). Data related to treatment included diagnosis, staging, site involved, need for neck dissection, free flap type, adjuvant treatments and need for permanent feeding or breathing support (i.e., tracheostomy, percutaneous endoscopic gastrostomy \[PEG\]).

The validated Italian version of the Medical Outcome Study's (MOS's) 36-item Short-Form Health Survey (SF-36), administered at least 24 months after surgery, was used to assess QOL ^[@ref12]^. The SF-36 investigates eight fields of global health, focusing on emotional and physical aspects, with scores ranging from 0 to 100. The Short Form 12 (SF-12) can be used to condense SF-36 scores into the medical component summary (MCS) and physical component summary (PCS) scores, simplifying analysis of data ^[@ref13]^. Results with the SF-12 were compared to those for the general Italian population of the same age using a database of 61,434 questionnaires completed by Italian subjects ^[@ref14]^.

Results {#sec1-3}
=======

For the period considered, 115 patients met inclusion criteria. 76 (66.1%) of patients died before data collection and were not included. Thus, the study cohort consisted of 39 patients (19 males and 20 females) with an average age at the time of surgery of 80.6 ± 4.40 years (maximum age, 89 years; [Table I](#table001){ref-type="table"}). The average follow-up duration was 49.3 months (range, 24-132 months). Comorbidities (86% of which were cardiovascular disease) were recorded in 32 patients. ASA indices were 3 for 59% of patients, 2 for 33% of patients, 4 for 5% of patients and 1 for 2% of patients. In all, 15 patients were smokers, 11 abused alcohol and 8 had both habits. All patients required microvascular reconstruction due to malignant pathology: 33 patients had squamous cell carcinoma of the oral cavity, 4 had cutaneous squamous cell carcinoma, 1 was treated for basal cell carcinoma infiltrating the maxilla and 1 had adenocarcinoma of the minor salivary gland. The most frequently involved oral-cavity site was the mandible (in 36% of patients), followed by the tongue (21%), cheek (13%), maxilla (13%), and floor of the mouth (8%). The skin was involved in 10% of patients. 20 (51%) patients had advanced (stage IV) disease, six had stage III, 9 had stage II and 4 had stage I disease. Bone-containing free flaps were used in 7 patients (five fibula flaps, two iliac crest flaps), and the most frequently used flap was the radial forearm free flap (n = 20). Other flaps harvested were the latissimus dorsi (n = 10) and antero-lateral thigh (ALT; n = 2) flaps. Neck dissection was performed in 30 patients. 23 patients underwent post-surgical adjuvant radiotherapy, two underwent chemotherapy and 1 patient was given both treatments. No permanent tracheostomies were recorded; three patients underwent permanent PEG. We recorded 10 cases of disease relapse, and three patients died after completing the questionnaire.

The questionnaire results are summarised in [Table II](#table002){ref-type="table"}. The average score for all patient scales was 68.29 ± 27.30; the highest score was for physical function (76.92 ± 25.35) and the lowest score was for energy/fatigue (60.25 ± 19.26). SF-12 results are shown in [Figures 1-3](#fig001 fig002 fig003){ref-type="fig"}. We divided the cohort into two groups according to sex and compared our results with those from the control group, which comprised 5,283 Italian people aged \> 75 years. The most evident difference was in the PCS score (46.53 vs 37.85), which indicated that our patients perceive themselves to have a better physical status than their counterparts from the general population.

Discussion {#sec1-4}
==========

When surgical results after head and neck resection and reconstruction in the elderly population are analysed, several major issues must be considered. The most relevant issues are that most of these patients are extremely frail, and long-term follow-up is difficult to achieve due to death of subjects resulting from multiple possible events (e.g., cardiovascular events, secondary tumour development). Our case series confirms this trend, as two-thirds of patients died before our retrospective evaluation, which makes assessment of the real impacts of these procedures on patient survival and the effectiveness of reconstructive surgery in terms of QOL extremely difficult. Moreover, recruitment of survivors introduces selection bias because this group likely includes only those with the highest performance status, partially affecting comparison with the general population of the same age. This bias was further increased in our series because we considered only patients who were candidates for free-flap surgery, resulting in the exclusion of those in worst general condition at the time of treatment.

No consensus has been reached in the international literature on the official definition of "elderly", with various cut-off ages used in different studies ^[@ref15]^. However, 75-80 years of age is considered worldwide to be a well-defined landmark, probably because the percentage of comorbidities and general performance status are more constant in individuals who have reached this age range than in the younger population, in which these parameters can markedly differ among patients of the same age and are usually considered the most important criteria in patient evaluation.

All of these findings underline the difficulty of dealing with this specific group of patients and partially explain the relative paucity of papers with a large series of elderly patients ^[@ref18]^. Our inclusion criteria were thus quite broad, and the data were not stratified based on surgical site or adjuvant treatment. This approach was taken in part due to the small sample, and in part based on our goal of examining the impact of free-flap surgery in these subjects. We believe that it was adequate for the examination of patients in this cohort.

Few studies have focused on QOL in these elderly subjects, probably due to the difficulty of analyses. A multi-centric study design is mandatory to achieve a sufficiently large study cohort for such analyses. Although its importance is often underestimated, long-term QOL is of extreme relevance in analyses of surgical results because it represents a final assessment of treatment; thus, it should be considered a real outcome to measure ^[@ref19]^, particularly for patients with relatively short remaining life expectancies, such as octogenarians. The intent is to assess whether major surgical procedures, usually considered the best reconstructive options in the general population ^[@ref20]^, are justified by the achievement of satisfactory QOL, or whether possible associated risks and shortcomings ^[@ref21][@ref22]^, which can lead to impairment and other consequences that compromise final outcomes, outweigh potential benefits.

QOL should be assessed through analyses of daily life activities and functions, and questionnaires are considered among the best methods by which to investigate this parameter ^[@ref23][@ref24]^. When results from the general population are available, comparison with cohort data can further improve the value of the results and provide a more objective view of the scores. This consideration is the main reason that we chose to use the SF-36 and SF-12. Our choice was also made with consideration of the availability of the questionnaire in patients' native language and its international validation ^[@ref12]^. The results of this study are quite encouraging, particularly in consideration of physical impairment; the mean general physical function was 76.92/100, and pain (72.76/100) was not an issue for our patients. Energy/fatigue and general health were the most relevant problems, with scores of 60.25 and 60.48/100, respectively, but these factors are probably those most biased by the age of the subjects. SF-12 scores were comparable with those of the general population; the PCS score was slightly better than that of the control group, and the MCS score was basically the same as that from the general population. Considering the selection of the "healthiest" subjects based on the indication for free-flap procedures, this analysis showed that free-flap reconstruction does not worsen the quality of residual life in elderly patients. These findings, together with those from the literature, confirm that free-flap success rates and complications in this population are comparable to those in younger patients, which should help surgeons in surgical planning, reducing concerns about elderly patients' post-surgical daily lives.

Conclusions {#sec1-5}
===========

Our data support the indication for free-flap reconstruction of head and neck defects in the elderly population. In particular, the quality of residual life seems to be comparable to that in the general population of the same age. Further studies should be conducted to assess whether the high mortality rate is related only to general age-related risks, or whether major surgical procedures play a contributing role.
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###### 

Patient characteristics (n = 39).

                                            N (%)
  ----------------------------------------- ------------
  Sex                                       
      Male                                  19 (49%)
      Female                                20\. (51%)
  Comorbidities                             
      Yes                                   22 (56%)
      Renal                                 0\. (0%)
      Pulmonary                             2 (5%)
      Cardiovascular                        19 (49%)
      Hepatic                               1 (2%)
      No                                    17 (44%)
  Smoking                                   
      Yes                                   15 (38%)
      No                                    24 (62%)
  Alcol                                     
      Yes                                   11 (28%)
      No                                    28 (72%)
  ASA                                       
      I                                     1 (2%)
      II                                    13 (33%)
      III                                   23 (60%)
      IV                                    2 (5%)
  Pathology                                 
      Squamous cell carcinoma oral cavity   33 (87%)
      Cutaneous squamous cell carcinoma     4 (9%)
      Cutaneous basal cell carcinoma        1 (2%)
      Adenocacinoma salivary gland          1 (2%)
  Tumour site                               
      Mandible                              14 (36%)
      Tongue                                8 (21%)
      Maxillary bone                        5 (13%)
      Cheek                                 5 (13%)
      Floor of the mouth                    3 (8%)
      Skin                                  4 (9%)
  Disease stage                             
      I                                     4 (9%)
      II                                    9 (24%)
      III                                   6 (16%)
      IV                                    20 (51%)
  Type of flap                              
      Forearm                               20 (51%)
      Fibula                                5 (13%)
      Iliac crest                           2 (5%)
      ALT                                   10 (26%)
      Latissimus dorsi                      2 (5%)
  Neck dissection                           
      Yes                                   7 (18%)
      No                                    32 (72%)
  Adjuvant therapy                          
      Yes                                   26 (67%)
      No                                    13 (33%)

###### 

Results obtained in the 8 fields of SF-36 questionnaires.

  SF-36                                        Mean   Average   SD        Min   Max
  -------------------------------------------- ------ --------- --------- ----- -----
  Physical functioning                         85     76.92     ± 25.35   0     100
  Role limitations due to physical health      100    66.66     ± 41.09   0     100
  Pain                                         74     72.76     ± 27.18   0     100
  General health                               61     60.48     ± 17.85   25    100
  Energy/fatigue                               60     60.25     ± 19.26   15    95
  Social functioning                           75     72.23     ± 24.87   0     100
  Role limitations due to emotional problems   100    67.46     ± 43.62   0     100
  Emotional well-being                         72     69.53     ± 19.15   28    100
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